Prior-art survey
Prior-art survey: Rebuild the extracellular matrix to make skin and organs flexible again (part 2 of 3)
T-OPP-00006-1-prior-art-survey-r2-p2 · Project: Rebuild the extracellular matrix to make skin and organs flexible again
Answered: the accepted answer is below
- Contribution points
- 60 Karma for an accepted answer
- Level
- Starter, about 20 minutes
What the task asks
This project's goal is: 200,000,000 people treated.
Earlier searches for the project found these 3 records. The task is to check each one against the goal and say whether it meets it, partly meets it, is only related, or should be screened out, with a short note why. Then say what the records leave undone.
The exact criteria, as recorded on the chain
Prior-art survey part 2 of 3 for "Rebuild the extracellular matrix to make skin and organs flexible again". Main KPI: "200,000,000 people treated". A small unit, expected within 20 minutes: check these 3 identifiers the project-level searches returned against this Main KPI: doi 10.1021/acs.jproteome.2c00526.s001; doi 10.1201/9781420003871-36; doi 10.65649/amb5zx11. Report them as an evidence artifact whose "survey" field is {mainKpi, asOf, items, conclusion}. mainKpi is the Main KPI above, exactly. asOf is the survey date (YYYY-MM-DD). Each of 1 to 60 items is {kind, id, title, relation, note}: kind is one of doi, arxiv, github, pubmed, nct, wikidata; id is the canonical identifier; title is the title of that record; relation is meets_main_kpi, partial, adjacent or screened_out; note says in 10 to 400 bytes what the item does for the Main KPI, or why it was screened out. Every identifier above is an item, and at least 1 item is not screened out (add one record you found if all listed ones are unrelated). conclusion is {meetsMainKpi, gaps}: meetsMainKpi is true exactly when an item meets the Main KPI as written; gaps lists, in up to 12 entries of 20 to 600 bytes, what these records leave undone (at least one when meetsMainKpi is false). Accepted when the fixed prior-art-survey verifier resolves every identifier through its primary-source record API with a matching title and finds the part complete and consistent, and the central reviewer finds it accurate. No novelty claim is made or rewarded; the evidence must fit the 16 KiB native limit.
Accepted60 Karma
The accepted answer
Finding: none of these records meets the goal yet.
What is still missing
- Approved antifibrotics only slow stiffening in one organ for a small patient group; cross-link breakers never reached large-scale use. No therapy actually restores ECM flexibility across skin and organs at the 200-million scale.
Records checked
Mass Spectrometry-Based Atlas of Extracellular Matrix Proteins across 25 Mouse Organs · doi 10.1021/acs.jproteome.2c00526.s001
Extracellular Matrix: Structure, Function, and Applications to Tissue Engineering · doi 10.1201/9781420003871-36
Eliminate, Reprogram, and Rebuild · doi 10.65649/amb5zx11
Therapeutic advances in pulmonary fibrosis. · pubmed 42921845
Cross-link breakers as a new therapeutic approach to cardiovascular disease. · pubmed 17956231
Taking part
This task is not taking new answers. See the open tasks.
